CAS 862507-23-1

LY2228820

CAS: 862507-23-1

Formel: C₂₆H₃₇FN₆O₆S₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 612.7370

Ref: IN-DA00GU43

LY2228820

CAS: 862507-23-1

LY2228820

Formel: C₂₄H₂₉FN₆·2CH₃SO₃H

Farbe und Form: Solid-Powder

Molekulargewicht: 612.73698

Ref: 54-BISN0222

Ralimetinib dimesylate

CAS: 862507-23-1

Ralimetinib dimesylate

Formel: C₂₄H₂₉FN₆·2CH₄O₃S

Reinheit: ≥98%

Molekulargewicht: 612.74

Ref: 54-BUP04719

Ralimetinib dimesylate

CAS: 862507-23-1

5-(2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate

Formel: C₂₆H₃₇FN₆O₆S₂

Reinheit: 98%

Molekulargewicht: 612.74

Ref: IN-DG306011

Ralimetinib dimesylate

CAS: 862507-23-1

Ralimetinib dimesylate (LY2228820 dimesylate) is a orally available, p38 MAPK inhibitor with potential anti-inflammatory and antineoplastic activities.

Formel: C₂₄H₂₉FN₆·2CH₄O₃S

Reinheit: 98% - 99.38%

Farbe und Form: White Solid

Molekulargewicht: 612.74

Ref: TM-T6047

LY 2228820

Kontrolliertes Produkt

CAS: 862507-23-1

Formel: C₂₄H₂₉FN₆

Farbe und Form: Neat

Molekulargewicht: 420.526

Ref: TR-L486500

LY 2228820 dimesylate

CAS: 862507-23-1

Inhibitor of p38 mitogen-activated protein kinase

Formel: C₂₆H₃₇FN₆O₆S₂

Reinheit: Min. 95%

Molekulargewicht: 612.74 g/mol

Ref: 3D-FL24961